Home World News EMA Recommends Extension of Therapeutic Indications for Acalabrutinib World News EMA Recommends Extension of Therapeutic Indications for Acalabrutinib By Ogkologos - June 18, 2025 840 0 Facebook Twitter Google+ Pinterest WhatsApp A new indication concerns the treatment of adult patients with previously untreated CLL in combination with venetoclax Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Today is Veterans Day November 11, 2020 High Jumper Training for Her Fifth Olympics Uses Personal Breast Cancer... December 9, 2020 Spotlight On: Exercise Physiologists in Cancer Care November 16, 2023 FDA Approves Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma March 25, 2022 Load more HOT NEWS Peace ESMO Highlights the Importance of a Strong EU Commitment Towards Robust... EMA Recommends Extending Indications for Trastuzumab Deruxtecan to Include Treatment of... Five Questions with…Jennifer.
